In a just published perspective piece in The New England Journal of Medicine, U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb, M.D.
pain management
Between increased competition for limited resources in research funding and medical conditions that have powerful and prominent champions, among other issues, it can be especially challenging for rarer conditions like Sickle Cell Disease to remain
Pain management remains a national issue entangled and exacerbated by the simple fact that our available pain medications have significant side effects, from constipation to addiction.
Aric Hausknecht, M.D., (1) who is a neurologist and a specialist in pain management, kindly agreed to speak with me about how changing opioid laws and regulations have affected his practice and patients, as well as w
